NIT
SRPT icon

NumerixS Investment Technologies’s Sarepta Therapeutics SRPT Stock Holding History

NumerixS Investment Technologies’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,915
Closed -$467K – 733
2020
Q2 		$467K Buy
2,915
+2,415
+483% +$329K 0.13% 179
2020
Q1 		$49K Buy
500
+300
+150% +$34.3K 0.03% 617
2019
Q4 		$26K Buy
+200
New +$20.2K 0.01% 913
2017
Q1 		– Sell
-9,293
Closed -$255K – 1358
2016
Q4 		$255K Buy
+9,293
New +$373K 0.03% 597

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NumerixS Investment Technologies's SRPT Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Sarepta Therapeutics (SRPT) in Q3 2020, closing a stake of 2,915 shares — an estimated $467K sold.

NumerixS Investment Technologies first reported a position in SRPT in Q4 2016 and held it in 4 quarters. The position peaked at $467K in Q2 2020. 403 funds tracked by Wall St. Rank hold SRPT as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Sarepta Therapeutics position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 2,915 Sarepta Therapeutics shares in Q3 2020, an estimated $467K.
  • NumerixS Investment Technologies first reported a position in Sarepta Therapeutics in Q4 2016 and held it in 4 quarters.
  • NumerixS Investment Technologies's Sarepta Therapeutics position peaked at $467K in Q2 2020.
  • 403 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.